Replies to post #387770 on Amarin Corp Plc (AMRN)

[couldbebetter]

Zip, As much as I agree with you on your points, any "new" version of
Vascepa, if one were approved, in my opinion would have to be rebranded
and promoted (owned) by a BP. Dr. Bhatt is obviously the world's leading
expert on Vascepa and he is on the BMY BOD. Would Dr. Bhatt want his
expertise to be wasted on a weak AMRN with a dismal BOD and management
team? Or, would he want this amazing drug to be owned by a BP that could
actually develop it into a world-class mega-blockbuster product? If anyone
should desperately want to see Vascepa as a successful Cardiovascular drug
it should be him. (Maybe Denner would be #2.) I wonder what Dr. Bhatt would
like to see happen at AMRN to assure Vascepa receive its, uhm, due? My hope
is that both Bhatt and Denner will use their influence to insure Vascepa succeeds!

[Whalatane]

Zip. U are detailing a 3 yr plan that AMRN would need a capital raise to complete.

Here’s a 3 month plan
Get Germany to reimburse for secondary prevention at a price AMRN can make $ on …arbitration decision in Nov . If Germany reimburses other EU countries likely to follow

Data from RESPECT and / or MITIGATE trials to confirm CV event reduction using EPA …. Some data should also be available by end of Nov at latest …. If not a reason why not

If we get both those we will have lift off in the EU

Kiwi